Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2022-01-24 Governance Information
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled as an "Investor Relations Management System" issued by the board of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the company's policies, principles, responsibilities, and procedures for managing investor relations. It includes governance structure, communication methods, disclosure principles, and compliance with relevant laws and stock exchange rules. There is no financial data, earnings information, or report publication announcement. It is a governance-related document focusing on investor relations management practices and internal rules. Therefore, it fits best under Governance Information (CGR). The document length (5835 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2022-01-24 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed disclosure management system of a company, outlining the principles, procedures, and responsibilities related to information disclosure. It extensively covers the requirements for periodic reports (annual, interim, quarterly), temporary reports, major transactions, insider information management, and other regulatory compliance aspects. It references regulatory bodies such as the China Securities Regulatory Commission and the Beijing Stock Exchange, and discusses the preparation, approval, and disclosure of financial reports and other material information. The document is not an actual financial report, earnings release, or announcement of voting results, but rather a comprehensive internal policy and governance document related to information disclosure. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices, including information disclosure policies.
2022-01-24 Chinese
独立董事工作制度
Governance Information Classification · 95% confidence The document is titled as an "Independent Director Work System" of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the rules, conditions, rights, and obligations of independent directors, including nomination, election, and reporting requirements. The content is about governance structure and internal rules related to the board and independent directors. There is no financial data, earnings information, or audit content. It is not a report or announcement of financial results or capital changes. The document fits the description of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2022-01-24 Chinese
独立董事关于第三届董事会第三次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the third meeting of the third board of directors of Inner Mongolia Datang Pharmaceutical Co., Ltd. It includes opinions on amendments to the profit distribution management system and the establishment of an external director and supervisor allowance management system. The document references compliance with company law and stock exchange listing rules, and it is a formal announcement of board opinions rather than a full report or financial statement. The document length is short (906 characters), and it does not contain financial data or detailed report content. It is not a report itself but an announcement related to board/management information, specifically about board meeting decisions and opinions. Therefore, the appropriate classification is Board/Management Information (MANG).
2022-01-24 Chinese
第三届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the third meeting of the third board of directors of Inner Mongolia Datang Pharmaceutical Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to various company governance documents and policies. The content focuses on board decisions, amendments to company bylaws, management systems, and other internal governance matters. There is no financial data, earnings information, or audit content. The document is not a full annual or interim report, nor is it a call transcript or capital update. It is clearly an announcement related to board/management decisions and changes. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (8513 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2022-01-24 Chinese
内幕信息知情人登记制度
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of the establishment and content of an "Insider Information Knowers Registration System" by the board of directors of Inner Mongolia Datang Pharmaceutical Co., Ltd. It includes the board meeting resolution, the scope of insider information, the range of insiders, registration and filing procedures, confidentiality management, and penalties. There are no financial statements, earnings data, or investor presentation content. It is not a report of financial results or an audit. It is a regulatory announcement about internal governance and compliance procedures related to insider information management. This fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other categories like Board/Management Information (MANG) since it is about insider information management system rather than personnel changes.
2022-01-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.